• Profile
Close

Endostatin is an independent risk factor of graft loss after kidney transplant

American Journal of Nephrology Apr 25, 2020

Chu C, Hasan AA, Gaballa MMS, et al. - Researchers analyzed 574 maintenance kidney transplant recipients (KTRs) in this prospective observational cohort study, to determine how graft loss level in KTRs is impacted by endostatin (a 20-kDa C-terminal fragment of collagen XVIII, recognized as inhibitor of the proliferation of capillary endothelial cells). A median follow-up of 48 months was performed for kidney graft loss and all-cause mortality. There were overall 574 patients, of those, 37 encountered graft loss, and 62 died. Based on receiver operating characteristics analysis, the optimal cut-off value of endostatin for graft loss was estimated to be 147.3 pmol/L. Findings revealed an independent link of increased serum endostatin at baseline with the risk of graft loss in KTRs.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay